Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

848 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
Goodman SG, Langer A, Durica SS, Raskob GE, Comp PC, Gray RJ, Hall JH, Kelley RP, Hua TA, Lee RJ, et al. Goodman SG, et al. Among authors: langer a. Am J Cardiol. 1994 Oct 1;74(7):657-61. doi: 10.1016/0002-9149(94)90305-0. Am J Cardiol. 1994. PMID: 7942522 Clinical Trial.
PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
Goodman S, Hill C, Bata I, Fung A, Higginson L, Lam J, Massel D, McCans J, Nasmith J, Stanton E, Thompson C, Warnica W, Langer A. Goodman S, et al. Among authors: langer a. Can J Cardiol. 1996 Nov;12(11):1183-90. Can J Cardiol. 1996. PMID: 9191511 Clinical Trial.
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.
Goodman SG, Cohen M, Bigonzi F, Gurfinkel EP, Radley DR, Le Iouer V, Fromell GJ, Demers C, Turpie AG, Califf RM, Fox KA, Langer A. Goodman SG, et al. Among authors: langer a. J Am Coll Cardiol. 2000 Sep;36(3):693-8. doi: 10.1016/s0735-1097(00)00808-1. J Am Coll Cardiol. 2000. PMID: 10987586 Free article. Clinical Trial.
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS).
O'Connor CM, Gattis WA, Hellkamp AS, Langer A, Larsen RL, Harrington RA, Berkowitz SD, O'Gara PT, Kopecky SL, Gheorghiade M, Daly R, Califf RM, Fuster V. O'Connor CM, et al. Among authors: langer a. Am J Cardiol. 2001 Sep 1;88(5):541-6. doi: 10.1016/s0002-9149(01)01735-0. Am J Cardiol. 2001. PMID: 11524065 Clinical Trial.
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Langer A, Krucoff MW, Klootwijk P, Veldkamp R, Simoons ML, Granger C, Califf RM, Armstrong PW. Langer A, et al. J Am Coll Cardiol. 1995 Jun;25(7):1552-7. doi: 10.1016/0735-1097(95)00110-p. J Am Coll Cardiol. 1995. PMID: 7759706 Free article. Clinical Trial.
848 results